Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Schedule of Earning Per Share

Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

 

   

Three Months Ended

March 31,

  
    2021     2020  
Net loss computation of basic and diluted net loss per common share:                
Net loss   $ (6,053,659 )   $ (3,754,659 )
Less: Redemption of Series D Preferred Stock deemed dividend     -       (1,295,294 )
Net loss attributable to common stockholders   $ (6,053,659 )   $ (5,049,953 )
                 
Basic and diluted net loss per share:                
Basic net loss per common share   $ (0.09 )   $ (0.43 )
                 
Basic weighted average common shares outstanding     67,593,607       8,679,959  
Diluted net loss per common share   $ (0.09 )   $ (0.43 )
                 
Diluted weighted average common shares outstanding     67,593,607       8,679,959  
Schedule of Potential Dilutive Securities

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows as of March 31, (in common equivalent shares):

 

    2021     2020  
Preferred shares     -       356,300  
Warrants     16,516,562       1,274,102  
Series A & B Notes     -       535,105  
Options and restricted stock units     203,135       112,500  
Total anti-dilutive weighted average shares     16,719,697       2,278,007